First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
This press release is not intended for US or UK media. Ingelheim, Germany and Ridgefield, Conn. Boehringer Ingelheim today announced that The New England Journal of Medicine (NEJM) published results ...
MedPage Today on MSN
Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line
Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...
The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung ...
“Lung cancer, though common and serious, still has many misconceptions,” says Ian Bostock, MD, a thoracic surgeon at Miami Cancer Institute in Florida. “Clearing these myths helps patients and ...
Lung cancer is classified into non-small cell and small cell types, influencing treatment strategies and prognosis. Advances in targeted therapies, immunotherapy, and minimally invasive surgeries have ...
You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical ...
The non-small cell lung cancer clinical trial analysis report delivers important insights into ongoing research of 120+ ...
The 84-year-old Navy veteran, whose real name is Kenny Jary, boasts over 4 million followers across social media platforms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results